The Australian Federal Government allocated A$250 million ($277.86 million) in GP funding each year for three years, plus A$143.3 million ($159.27 million) for rural and remote healthcare and A$229.7 million ($255.31 million) in general practice support grants
The Australian Federal Government allocated A$250 million ($277.86 million) in GP funding each year for three years, plus A$143.3 million ($159.27 million) for rural and remote healthcare and A$229.7 million ($255.31 million) in general practice support grants
Delays caused by Attention Deficit Hyperactivity Disorder medication regulations are worsened by “an absolute wave” of adults reporting symptoms of the disorder, says RNZCGP president and specialist GP Samantha Murton
The only meningococcal vaccine funded for students in university halls does not protect against the most common cause of the potentially deadly disease
Te Pātaka Whaioranga – Pharmac has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (brand name Prevenar 13) as part of the childhood immunisation programme, instead of the currently funded PCV10 vaccine (brand name Synflorix)
Te Pātaka Whaioranga Pharmac is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that means any medicine currently used to treat cancer in a paediatric setting is automatically funded without a Pharmac assessment
Delays caused by medication regulations are being worsened by “an absolute wave” of adults reporting ADHD symptoms, says RNZCGP president and specialist GP Sam Murton
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management